Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers Proxima, a cloud-based platform to store, analyze, and share spatial data; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.
Over the last 12 months, insiders at Akoya Biosciences, Inc. have bought $151,829 and sold $203,317 worth of Akoya Biosciences, Inc. stock.
On average, over the past 5 years, insiders at Akoya Biosciences, Inc. have bought $4.35M and sold $906,500 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Pla Frederic (Chief Operating Officer) — $151,829.
The last purchase of 20,000 shares for transaction amount of $92,014 was made by Pla Frederic (Chief Operating Officer) on 2023‑09‑07.
2024-06-11 | Sale | McKelligon Brian | President and CEO | 7,500 0.0145% | $2.08 | $15,630 | +1.83% | |
2024-06-06 | Sale | McKelligon Brian | President and CEO | 7,500 0.0146% | $2.01 | $15,064 | +5.74% | |
2024-03-20 | Sale | McKelligon Brian | President and CEO | 7,500 0.015% | $4.97 | $37,243 | -24.31% | |
2024-03-13 | Sale | McKelligon Brian | President and CEO | 7,500 0.0155% | $4.94 | $37,043 | -21.22% | |
2023-12-19 | Sale | McKelligon Brian | President and CEO | 7,500 0.0146% | $4.48 | $33,566 | -2.23% | |
2023-12-12 | Sale | McKelligon Brian | President and CEO | 7,500 0.0152% | $4.25 | $31,871 | +7.04% | |
2023-11-20 | Sale | McKelligon Brian | President and CEO | 7,500 0.0155% | $4.39 | $32,901 | +2.05% | |
2023-09-07 | Pla Frederic | Chief Operating Officer | 20,000 0.0412% | $4.60 | $92,014 | -4.07% | ||
2023-09-07 | Pla Frederic | Chief Operating Officer | 13,000 0.0268% | $4.60 | $59,814 | -4.07% | ||
2023-06-12 | Raffin Thomas A. | director | 2.02M 4.8443% | $5.00 | $10.1M | -13.79% | ||
2023-06-12 | Winkler Matthew | director | 203,388 0.4878% | $5.00 | $1.02M | -13.79% | ||
2023-06-12 | SHEPLER ROBERT G | director | 120,000 0.2878% | $5.00 | $600,000 | -13.79% | ||
2023-06-12 | Mendel Scott | director | 20,000 0.048% | $5.00 | $100,000 | -13.79% | ||
2023-06-12 | LAI GOLDMAN MYLA | director | 20,000 0.048% | $5.00 | $100,000 | -13.79% | ||
2023-06-12 | Ek John Frederick | CFO | 20,000 0.048% | $5.00 | $100,000 | -13.79% | ||
2023-06-06 | Sale | McKelligon Brian | President/CEO | 5,000 0.0131% | $5.71 | $28,537 | -16.67% | |
2023-03-14 | Sale | McKelligon Brian | President/CEO | 5,000 0.0135% | $9.17 | $45,852 | -39.18% | |
2022-12-14 | Sale | DRISCOLL JOSEPH | Chief Financial Officer | 14,574 0.0386% | $12.46 | $181,519 | -45.72% | |
2022-12-13 | Sale | SCHNETTLER THOMAS P | director | 71,050 0.1938% | $13.03 | $925,782 | -46.46% | |
2022-12-13 | Sale | Nolan Garry Ph.D. | director | 100 0.0003% | $13.25 | $1,325 | -46.46% |
McKelligon Brian | President and CEO | 224733 0.3109% | $2.58 | 0 | 12 | |
Pla Frederic | Chief Operating Officer | 13000 0.0265% | $2.58 | 2 | 0 | |
Raffin Thomas A. | director | 15937535 32.4751% | $2.58 | 1 | 0 | <0.0001% |
SCHNETTLER THOMAS P | director | 2742721 5.5887% | $2.58 | 0 | 1 | |
Winkler Matthew | director | 984513 2.0061% | $2.58 | 1 | 0 | <0.0001% |
Nolan Garry Ph.D. | director | 555084 1.1311% | $2.58 | 0 | 12 | |
SHEPLER ROBERT G | director | 369592 0.7531% | $2.58 | 2 | 0 | <0.0001% |
Mendel Scott | director | 28500 0.0581% | $2.58 | 2 | 0 | <0.0001% |
Ramachandran Niro Ph.D | Chief Business Officer | 25073 0.0511% | $2.58 | 2 | 0 | <0.0001% |
LAI GOLDMAN MYLA | director | 20000 0.0408% | $2.58 | 1 | 0 | <0.0001% |
Ek John Frederick | CFO | 20000 0.0408% | $2.58 | 1 | 0 | <0.0001% |
DRISCOLL JOSEPH | Chief Financial Officer | 12500 0.0255% | $2.58 | 0 | 1 |
Blue Water Life Science Advisors Llc | $22.03M | 9.51 | 4.7M | 0% | +$0 | 20.72 | |
Polar Capital | $7.41M | 3.2 | 1.58M | 0% | +$0 | 0.04 | |
The Vanguard Group | $6.82M | 2.95 | 1.45M | +3.28% | +$216,354.40 | <0.0001 | |
BlackRock | $6.32M | 2.73 | 1.35M | -1.8% | -$115,810.17 | <0.0001 | |
Parkman Healthcare Partners Llc | $4.3M | 1.86 | 917,442 | +35.96% | +$1.14M | 0.53 | |
Uniplan Investment Counsel Inc | $3.28M | 1.42 | 699,837 | +3.91% | +$123,403.80 | 0.27 | |
Silvercrest Asset Management Group Inc | $2.72M | 1.18 | 580,834 | New | +$2.72M | 0.02 | |
Boston Private Wealth Llc | $2.42M | 1.04 | 515,317 | 0% | +$0 | 0.05 | |
Geode Capital Management | $2.41M | 1.04 | 514,049 | +3.19% | +$74,457.00 | <0.0001 | |
State Street | $2.01M | 0.87 | 428,327 | +19.78% | +$331,751.90 | <0.0001 | |
Schonfeld Group | $1.76M | 0.76 | 375,500 | +141.01% | +$1.03M | 0.01 | |
Peddock Capital Advisors LLC | $1.13M | 0.49 | 240,050 | -17.43% | -$237,642.40 | 0.3 | |
Northern Trust | $972,682.00 | 0.42 | 207,395 | -5.59% | -$57,597.86 | <0.0001 | |
Charles Schwab | $805,629.00 | 0.35 | 171,776 | -16.14% | -$155,112.29 | <0.0001 | |
Squarepoint Ops LLC | $648,524.00 | 0.28 | 138,278 | +42.66% | +$193,912.79 | <0.01 | |
Osterweis Capital Management | $591,554.00 | 0.26 | 126,131 | 0% | +$0 | 0.04 | |
Morgan Stanley | $299,063.00 | 0.13 | 63,766 | -26.54% | -$108,024.94 | <0.0001 | |
Citadel Advisors LLC | $284,205.00 | 0.12 | 60,598 | +352.29% | +$221,368.30 | <0.0001 | |
BNY Mellon | $272,203.00 | 0.12 | 58,039 | -31.58% | -$125,649.83 | <0.0001 | |
Renaissance Technologies | $238,000.00 | 0.1 | 50,700 | +6.96% | +$15,491.12 | <0.0001 | |
Millennium Management LLC | $236,474.00 | 0.1 | 50,421 | -67.96% | -$501,580.39 | <0.0001 | |
ZWJ Investment Counsel | $211,871.00 | 0.09 | 45,175 | 0% | +$0 | 0.01 | |
Nuveen | $191,479.00 | 0.08 | 40,827 | 0% | +$0 | <0.0001 | |
Ameriprise Financial | $163,446.00 | 0.07 | 34,850 | -12.93% | -$24,270.68 | <0.0001 | |
RhumbLine Advisers | $158,779.00 | 0.07 | 33,857 | +2.41% | +$3,742.38 | <0.0001 | |
Cubist Systematic Strategies | $135,919.00 | 0.06 | 28,981 | -11.72% | -$18,051.56 | <0.01 | |
Hightower Advisors | $128,000.00 | 0.06 | 27,200 | 0% | +$0 | <0.0001 | |
AllianceBernstein | $127,334.00 | 0.06 | 27,150 | 0% | +$0 | <0.0001 | |
Xtx Topco Ltd | $117,808.00 | 0.05 | 25,119 | New | +$117,808.00 | 0.01 | |
Marshall Wace | $103,259.00 | 0.05 | 22,017 | New | +$103,259.00 | <0.0001 | |
Deutsche Bank | $102,069.00 | 0.04 | 21,763 | 0% | +$0 | <0.0001 | |
UBS | $100,596.00 | 0.04 | 21,449 | -15.54% | -$18,516.15 | <0.0001 | |
Bridgeway Capital Management | $96,145.00 | 0.04 | 20,500 | New | +$96,145.00 | <0.01 | |
Dimensional Fund Advisors | $86,324.00 | 0.04 | 18,406 | 0% | +$0 | <0.0001 | |
Barclays | $84,000.00 | 0.04 | 17,928 | -46.31% | -$72,459.84 | <0.0001 | |
Sherbrooke Park Advisers Llc | $74,852.00 | 0.03 | 15,960 | New | +$74,852.00 | 0.02 | |
Gsa Capital Partners Llp | $74,000.00 | 0.03 | 15,765 | New | +$74,000.00 | 0.01 | |
JPMorgan Chase | $68,929.00 | 0.03 | 14,697 | -0.08% | -$56.28 | <0.0001 | |
Jane Street Capital | $63,066.00 | 0.03 | 13,447 | -39.07% | -$40,441.59 | <0.0001 | |
Goldman Sachs | $57,842.00 | 0.03 | 12,333 | +22.1% | +$10,468.12 | <0.0001 | |
Stephens Inc. | $58,489.00 | 0.03 | 12,471 | -28.26% | -$23,037.28 | <0.01 | |
New York State Common Retirement Fund | $55,000.00 | 0.02 | 11,829 | +0.23% | +$125.54 | <0.0001 | |
American International Group | $53,583.00 | 0.02 | 11,425 | -0.86% | -$464.31 | <0.0001 | |
Regal Investment Advisors | $53,560.00 | 0.02 | 11,420 | +2.51% | +$1,313.20 | <0.01 | |
Stifel | $50,318.00 | 0.02 | 10,729 | +0.39% | +$196.98 | <0.0001 | |
The Manufacturers Life Insurance Company | $49,977.00 | 0.02 | 10,656 | New | +$49,977.00 | <0.0001 | |
Bank of America | $45,483.00 | 0.02 | 9,698 | -55.8% | -$57,418.89 | <0.0001 | |
Wells Fargo | $32,483.00 | 0.01 | 6,926 | +15.49% | +$4,357.02 | <0.0001 | |
NISA Investment Advisors, LLC | $28,445.00 | 0.01 | 6,065 | +0.1% | +$28.14 | <0.0001 | |
Citigroup | $18,127.00 | 0.01 | 3,865 | +13.08% | +$2,096.45 | <0.0001 |